1. Home
  2. AKR vs CRNX Comparison

AKR vs CRNX Comparison

Compare AKR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKR
  • CRNX
  • Stock Information
  • Founded
  • AKR 1993
  • CRNX 2008
  • Country
  • AKR United States
  • CRNX United States
  • Employees
  • AKR N/A
  • CRNX N/A
  • Industry
  • AKR Real Estate Investment Trusts
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKR Real Estate
  • CRNX Health Care
  • Exchange
  • AKR Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • AKR 2.5B
  • CRNX 2.8B
  • IPO Year
  • AKR 1993
  • CRNX 2018
  • Fundamental
  • Price
  • AKR $19.04
  • CRNX $30.16
  • Analyst Decision
  • AKR Strong Buy
  • CRNX Strong Buy
  • Analyst Count
  • AKR 3
  • CRNX 10
  • Target Price
  • AKR $22.67
  • CRNX $75.00
  • AVG Volume (30 Days)
  • AKR 1.1M
  • CRNX 676.7K
  • Earning Date
  • AKR 07-29-2025
  • CRNX 08-07-2025
  • Dividend Yield
  • AKR 4.16%
  • CRNX N/A
  • EPS Growth
  • AKR 83.39
  • CRNX N/A
  • EPS
  • AKR 0.17
  • CRNX N/A
  • Revenue
  • AKR $387,331,000.00
  • CRNX $760,000.00
  • Revenue This Year
  • AKR N/A
  • CRNX $402.12
  • Revenue Next Year
  • AKR $11.00
  • CRNX $770.88
  • P/E Ratio
  • AKR $116.27
  • CRNX N/A
  • Revenue Growth
  • AKR 13.53
  • CRNX N/A
  • 52 Week Low
  • AKR $16.98
  • CRNX $24.10
  • 52 Week High
  • AKR $26.29
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • AKR 41.97
  • CRNX 41.11
  • Support Level
  • AKR $19.06
  • CRNX $32.05
  • Resistance Level
  • AKR $19.48
  • CRNX $31.56
  • Average True Range (ATR)
  • AKR 0.40
  • CRNX 1.08
  • MACD
  • AKR -0.02
  • CRNX -0.18
  • Stochastic Oscillator
  • AKR 15.00
  • CRNX 5.25

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: